Health and Fitness Health and Fitness
Mon, October 17, 2011
[ Mon, Oct 17th 2011 ] - Market Wire
Lilly Declares Fourth-Quarter 2011 Dividend
[ Mon, Oct 17th 2011 ] - Market Wire
Express Scripts Announces Third Quarter 2011 Earnings Conference Call
[ Mon, Oct 17th 2011 ] - Market Wire
Skilled Healthcare to Release Third Quarter 2011 Results on October 31, 2011
[ Mon, Oct 17th 2011 ] - Market Wire
Curis to Present at the BioCentury NewsMakers in the Biotech Industry Conference
[ Mon, Oct 17th 2011 ] - Market Wire
Izard Nobel LLP Announces Class Action Lawsuit Against Stereotaxis, Inc.
[ Mon, Oct 17th 2011 ] - Market Wire
Enzon Announces Management Change, Forms Special Committee of the Board
[ Mon, Oct 17th 2011 ] - Market Wire
Cubist Pharmaceuticals Appoints Jennifer Jackson as Senior Vice President, Regulatory Affairs
[ Mon, Oct 17th 2011 ] - Market Wire
Medtronic Elects Michael O. Leavitt to the Board of Directors
[ Mon, Oct 17th 2011 ] - Market Wire
OPKO Health to Share in NIH Grant Award
[ Mon, Oct 17th 2011 ] - Market Wire
Tripp Levy PLLC Announces Investigation of Anadys Pharmaceuticals
[ Mon, Oct 17th 2011 ] - Market Wire
TheraBiogen, Inc. Announces Financing Agreement With ECAP Capital to Fund Record Shipments
[ Mon, Oct 17th 2011 ] - Market Wire
Futuremed Announces Timing of Third Quarter 2011 Results &;; Conference Call
[ Mon, Oct 17th 2011 ] - Market Wire
Healthways Takes Its Commitment to Well-Being on .. nual Overnight Ragnar Relay Tennessee Partnership
[ Mon, Oct 17th 2011 ] - Market Wire
Leisureworld Announces October Dividend
[ Mon, Oct 17th 2011 ] - Market Wire
Medtronic Announces 510(k) Clearance for the Aqua .. ined Hemostatic Sealing and Cutting Functionality
[ Mon, Oct 17th 2011 ] - Market Wire
PharmStar Outstanding Common Stock Reduced by 50%
[ Mon, Oct 17th 2011 ] - Market Wire
AdCare Health Systems to Acquire Five Skilled Nursing Facilities in Oklahoma
[ Mon, Oct 17th 2011 ] - Market Wire
DMRJ Amends Implant Sciences' Credit Facility
[ Mon, Oct 17th 2011 ] - Market Wire
Marina Biotech, Inc. Announces a $15 Million Purc .. ase Agreement With Lincoln Park Capital Fund, LLC
[ Mon, Oct 17th 2011 ] - Market Wire
Lpath Initiates Dosing of iSONEP in Second of Two Proof-of-Concept Trials
[ Mon, Oct 17th 2011 ] - Market Wire
Immunovaccine Appoints Wayne Pisano to its Board
[ Mon, Oct 17th 2011 ] - Market Wire
Cellceutix Confident as Cancer Compound Shows Activity in All Cancers Tested
[ Mon, Oct 17th 2011 ] - Market Wire
Acura Pharmaceuticals Provides Update on Opioid Product Licensed to Pfizer
[ Mon, Oct 17th 2011 ] - Market Wire
CytoSorbents Corporation Launches HemoDefend Puri .. for Blood Transfusion Applications at the AABB Co
Sun, October 16, 2011
[ Sun, Oct 16th 2011 ] - Market Wire
China Medical Technologies Announces the Approval .. Technology Enterprise Status for a Major Subsidia
Sat, October 15, 2011
[ Sat, Oct 15th 2011 ] - Market Wire
The Medicines Company's MDCO-2010 Meets Clinical .. ectives in Patients Undergoing Open-Heart Surgery
Fri, October 14, 2011
[ Fri, Oct 14th 2011 ] - Market Wire
Newly Published Study Highlights Systemic Growth .. g" Market;; DRM Ventures (DRM) and Patient
[ Fri, Oct 14th 2011 ] - Market Wire
Sangamo BioSciences Announces Presentation at the .. ual Newsmakers in the Biotech Industry Conference
[ Fri, Oct 14th 2011 ] - Market Wire
Par Pharmaceutical Files Declaratory Judgment to .. s to Disseminate Truthful Information Regarding M
[ Fri, Oct 14th 2011 ] - Market Wire
MannKind to Present at The 18th Annual Newsmakers in the BioTech Industry Conference

MannKind to Present at The 18th Annual Newsmakers in the BioTech Industry Conference


Published on 2011-10-14 14:10:59 - Market Wire
  Print publication without navigation


VALENCIA, Calif.--([ BUSINESS WIRE ])--MannKind Corporation (Nasdaq: MNKD), focused on discovering, developing and commercializing treatments for diabetes and cancer, announced today that it will present at the 18th Annual Newsmakers in the BioTech Industry Conference presented by Thomson Reuters and BioCentury on Friday, October 21, 2011 at 8:30am (ET) at the Millennium Broadway Hotel in New York, New York.

Interested parties can access a link to the live webcast of the presentation from the News & Events section of the Company's website at [ http://www.mannkindcorp.com ].

About MannKind Corporation

MannKind Corporation (Nasdaq: MNKD) focuses on the discovery, development and commercialization of therapeutic products for patients with diseases such as diabetes and cancer. Its lead product candidate, AFREZZA®, is in late stage clinical investigation for the treatment of adults with type 1 or type 2 diabetes for the control of hyperglycemia. MannKind maintains a website at [ www.mannkindcorp.com ] to which MannKind regularly posts copies of its press releases as well as additional information about MannKind. Interested persons can subscribe on the MannKind website to e-mail alerts that are sent automatically when MannKind issues press releases, files its reports with the Securities and Exchange Commission or posts certain other information to the website.

Contributing Sources